News

Filter

Current filters:

Pricing

201 to 210 of 97574 results

Russia’s Nanolek commissions plant for production of nano-based drugs

12-01-2015

Russia's Nanolek has officially commissioned a new facility for the production of drugs for the treatment…

Antibiotics and Infectious diseasesCardio-vascularNanolekOncologyPharmaceuticalProductionRussia

Hospira submits new BLA for epoetin alfa biosimilar In USA

12-01-2015

US injectable drugs and infusion technologies and biosimilars developer Hospira has submitted a Biologics…

AmgenBiosimilarsBiotechnologyepoetinEpogenHematologyHospiraJanssenJohnson & JohnsonProcritRegulationRetacritUSA

Helsinn settles with Sandoz over Aloxi in USA

12-01-2015

Privately-held Swiss cancer specialist Helsinn Group say it has entered into a settlement agreement with…

AloxiEisaiGenericsHelsinn GroupLegalNovartisOncologyPatentsSandozUSA

EMA accepts Sanofi and Regeneron's MMA for Praluent for review

EMA accepts Sanofi and Regeneron's MMA for Praluent for review

12-01-2015

French drug major Sanofi and US biotech company Regeneron have announced that the European Medicines…

alirocumabBiotechnologyCardio-vascularEuropeRegeneronRegulationSanofi

Capsugel acquires Monash University’s proprietary ionic liquids technology

Capsugel acquires Monash University’s proprietary ionic liquids technology

12-01-2015

US capsule technology company Capsugel has acquired the intellectual property relating to proprietary…

AustraliaCapsugelGeneticsLicensingPharmaceuticalUSA

Australia needs targeted reform to reflect global regulatory environment: Medicines Australia chief

Australia needs targeted reform to reflect global regulatory environment: Medicines Australia chief

12-01-2015

Australian pharma representative body Medicines Australia has put forward its recommendations for consideration…

AustraliaMedicines AustraliaPharmaceuticalRegulationTechnology

Bristol-Myers stops Opdivo NSCLC study early on good results

12-01-2015

US pharma major Bristol-Myers Squibb says that an open-label, randomized Phase III study evaluating Opdivo…

Bristol-Myers SquibbOncologyOpdivoPharmaceuticalResearch

201 to 210 of 97574 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top